全球观点:亚洲前列腺癌流行病学和治疗模式的发展
Kagenori Ito1, Keiichiro Mori1, Rajeev Kumar2
1Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
BJU international
|August 25, 2025
概括
前列腺癌 (PCa) 呈现区域差异. 经济因素和医疗保健的获取在亚洲国家显著影响PCa的结果和生存率,尽管疾病的侵袭性各不相同.
科学领域:
- 尿道病学
- 流行病学
- 癌症学
背景情况:
- 前列腺癌的发病率和死亡率因地区而异.
- PCa的原因是复杂的和多因素的.
- 亚洲泌尿学协会成员国的PCa流行病学和结果存在显著差异.
研究的目的:
- 分析亚洲国家的PCa流行病学,临床特征,治疗疗效和生存趋势.
- 研究PCa发病率,死亡率和存活率的区域差异.
- 探索经济因素对亚洲合作伙伴关系成果的影响.
主要方法:
- 使用了GLOBOCAN 2022的发病率和死亡率数据.
- 纳入CONCORD-3研究数据进行生存分析.
- 包括国际货币基金组织对人均GDP等经济指标的数据库.
主要成果:
- 亚洲男性呈现出更激烈的PCa,但通常比高加索男性的生存率更好.
- 亚洲PCA发病率最低, 但由于医疗保健的有限, 发展中国家的死亡率正在上升.
- 亚洲发展中国家的五年生存率与人均GDP有正相关.
结论:
- 亚洲发达国家与发展中国家在PCa死亡率,查和治疗准入方面存在严重差异.
- 经济状况和卫生政策基础设施是亚洲合作伙伴关系成果的关键决定因素.
- 人均国内生产总值对亚洲人口的预后和生存率产生重大影响.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.2K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.7K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Disorders of the Male Reproductive System
575
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
575
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
